124P Durvalumab in advanced, pre-treated microsatellite instability-high solid tumors: Results of a tumor-agnostic DRUP trial cohort

Annals of Oncology, vol. 33, pp. S594

Authors 18

1. B.S. Geurts

   The Netherlands Cancer Institute

   Affiliation as printed

   Division of Molecular Oncology and Immunology, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

2. T. Battaglia

   The Netherlands Cancer Institute

   Affiliation as printed

   Division of Molecular Oncology and Immunology, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

3. Jade M. van Berge Henegouwen Aachen Medical Oncology Department

   Leiden University Medical Center

   Affiliation as printed

   Medical Oncology Department, LUMC - University Medical Center, Leiden, Netherlands

4. L.J. Zeverijn

   The Netherlands Cancer Institute

   Affiliation as printed

   Division of Molecular Oncology and Immunology, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

5. L.R. Hoes

   The Netherlands Cancer Institute

   Affiliation as printed

   Medical Oncology Department, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

6. Hanneke van der Wijngaart

   Amsterdam University Medical Centers · Vrije Universiteit Amsterdam · Amsterdam UMC Location Vrije Universiteit Amsterdam

   Affiliation as printed

   Medical Oncology Department, Amsterdam University Medical Center (UMC), location Vrije Universiteit Amsterdam, Amsterdam, Netherlands

7. G.F. de Wit

   The Netherlands Cancer Institute

   Affiliation as printed

   Division of Molecular Oncology and Immunology, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

8. P. Roepman

   Hartwig Medical Foundation

   Affiliation as printed

   Medical, Hartwig Medical Foundation, Amsterdam, Netherlands

9. A. Jansen

   University Medical Center Utrecht

   Affiliation as printed

   Pathology Department, UMC-University Medical Center Utrecht, Utrecht, Netherlands

10. W. de Leng

    University Medical Center Utrecht

    Affiliation as printed

    Pathology Department, UMC-University Medical Center Utrecht, Utrecht, Netherlands

11. Vincent van der Noort

    The Netherlands Cancer Institute

    Affiliation as printed

    Biometrics Department, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

12. F.L. Opdam

    The Netherlands Cancer Institute

    Affiliation as printed

    Clinical Pharmacology Department, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

13. A.D. Bins

    Amsterdam UMC Location University of Amsterdam · Amsterdam University Medical Centers · University of Amsterdam

    Affiliation as printed

    Medical Oncology Department, Amsterdam University Medical Center (UMC) - location University of Amsterdam, Amsterdam, Netherlands

14. J.W.B. de Groot

    Isala

    Affiliation as printed

    Oncology Center, Isala, Zwolle, Netherlands

15. M. Labots

    Amsterdam University Medical Centers · Vrije Universiteit Amsterdam · Amsterdam UMC Location Vrije Universiteit Amsterdam

    Affiliation as printed

    Medical Oncology Department, Amsterdam University Medical Center (UMC), location Vrije Universiteit Amsterdam, Amsterdam, Netherlands

16. H. Gelderblom Aachen Medical Oncology Department

    Leiden University Medical Center

    Affiliation as printed

    Medical Oncology Department, LUMC - University Medical Center, Leiden, Netherlands

17. H.M.W. Verheul

    Radboud University Medical Center

    Affiliation as printed

    Medical Oncology Department, Radboud University Medical Center, Nijmegen, Netherlands

18. E.E. Voest

    The Netherlands Cancer Institute

    Affiliation as printed

    Division of Molecular Oncology and Immunology, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands